share_log

Abeona Therapeutics | 8-K: Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Abeona Therapeutics | 8-K: Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Abeona Therapeutics | 8-K:Abeona Therapeutics® 公佈2024年第二季度財務業績並結束與美國食品藥品管理局的A類會議,以就即將提交的PZ-cel BLA重新提交達成一致
美股SEC公告 ·  2024/08/12 07:35
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息